William Romero

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum et al. · American Journal of Clinical Dermatology · 2021 · 128 citations · Full text

The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey

Giampiero Girolomoni, Thomas A. Luger, Audrey Nosbaum et al. · Dermatology and Therapy · 2020 · 72 citations · Full text

Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment

Marco Boeri, Jessie Sutphin, Brett Hauber et al. · Journal of Dermatological Treatment · 2020 · 42 citations · Full text

Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure

Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum et al. · American Journal of Clinical Dermatology · 2024 · 37 citations · Full text

Treatment of facial atrophic scars with Esthélis, a hyaluronic acid filler with polydense cohesive matrix (CPM).

Ariel Hasson, William Romero · PubMed · 2010 · 31 citations